Avalo Therapeutics Inc (AVTX) net margin is 16556.0%
Avalo Therapeutics Inc (AVTX) net margin is 16556.0% as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full AVTX research page for quote, filings, and the rest of the model. This satellite exists so “Avalo Therapeutics Inc net margin” can rank with the actual number, then send you to /stock/avtx.